Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the prevention and treatment of Selenium-Tocopherol Deficiency (white muscle disease) syndrome in calves.
LEARN MOREFor use in healthy swine as an aid in the control of ileitis caused by Lawsonia intracellularis, an aid in the reduction of colonization by Lawsonia, and an aid…
LEARN MORE